FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2468222296> ?p ?o ?g. }

• W2468222296 endingPage "50116" @default.
• W2468222296 startingPage "50099" @default.
• W2468222296 abstract "Macrophages enhance glioma development and progression by shaping the tumor microenvironment. Class A1 scavenger receptor (SR-A1), a pattern recognition receptor primarily expressed in macrophages, is up-regulated in many human solid tumors. We found that SR-A1 expression in 136 human gliomas was positively correlated with tumor grade (P<0.01), but not prognosis or tumor recurrence. SR-A1-expressing macrophages originated primarily from circulating monocytes attracted to tumor tissue, and were almost twice as numerous as resident microglia in glioma tissues (P<0.001). The effects of SR-A1 on glioma proliferation and invasion were assessed in vivo using an SR-A1-deficient murine orthotopic glioma model. SR-A1 deletion promoted M2-like tumor-associated macrophage (TAM) polarization in mice by activating STAT3 and STAT6, which resulted in robust orthotopic glioma proliferation and angiogenesis. Finally, we found that HSP70 might be an endogenous ligand that activates SR-A1-dependent anti-tumorigenic pathways in gliomas, although its expression does not appear informative for diagnostic purposes. Our findings demonstrate a relationship between TAMs, SR-A1 expression and glioma growth and provide new insights into the pathogenic role of TAMs in glioma." @default.
• W2468222296 created "2016-07-22" @default.
• W2468222296 creator A5003599939 @default.
• W2468222296 creator A5005324730 @default.
• W2468222296 creator A5010159755 @default.
• W2468222296 creator A5014708668 @default.
• W2468222296 creator A5018758426 @default.
• W2468222296 creator A5030844736 @default.
• W2468222296 creator A5035918316 @default.
• W2468222296 creator A5047871723 @default.
• W2468222296 creator A5065254789 @default.
• W2468222296 creator A5080611527 @default.
• W2468222296 creator A5080990690 @default.
• W2468222296 creator A5086664284 @default.
• W2468222296 date "2016-06-29" @default.
• W2468222296 modified "2023-10-01" @default.
• W2468222296 title "Class A1 scavenger receptor modulates glioma progression by regulating M2-like tumor-associated macrophage polarization" @default.
• W2468222296 cites W1414643142 @default.
• W2468222296 cites W1480357432 @default.
• W2468222296 cites W1482848424 @default.
• W2468222296 cites W148398836 @default.
• W2468222296 cites W1552252573 @default.
• W2468222296 cites W1586921439 @default.
• W2468222296 cites W1593681077 @default.
• W2468222296 cites W1893588436 @default.
• W2468222296 cites W1901239216 @default.
• W2468222296 cites W1964180981 @default.
• W2468222296 cites W1966577330 @default.
• W2468222296 cites W1969057487 @default.
• W2468222296 cites W1976556343 @default.
• W2468222296 cites W1978834636 @default.
• W2468222296 cites W1980485314 @default.
• W2468222296 cites W1983180112 @default.
• W2468222296 cites W1983827883 @default.
• W2468222296 cites W1992867900 @default.
• W2468222296 cites W1996024251 @default.
• W2468222296 cites W1997533142 @default.
• W2468222296 cites W2003674452 @default.
• W2468222296 cites W2005334224 @default.
• W2468222296 cites W2010662726 @default.
• W2468222296 cites W2015119709 @default.
• W2468222296 cites W2020452031 @default.
• W2468222296 cites W2021955841 @default.
• W2468222296 cites W2022485121 @default.
• W2468222296 cites W2022723787 @default.
• W2468222296 cites W2026703306 @default.
• W2468222296 cites W2031047943 @default.
• W2468222296 cites W2031667334 @default.
• W2468222296 cites W2032517243 @default.
• W2468222296 cites W2039183048 @default.
• W2468222296 cites W2040773741 @default.
• W2468222296 cites W2048898424 @default.
• W2468222296 cites W2053389410 @default.
• W2468222296 cites W2056241473 @default.
• W2468222296 cites W2058648826 @default.
• W2468222296 cites W2060564335 @default.
• W2468222296 cites W2068335734 @default.
• W2468222296 cites W2073586533 @default.
• W2468222296 cites W2080860848 @default.
• W2468222296 cites W2081810806 @default.
• W2468222296 cites W2092409918 @default.
• W2468222296 cites W2100575746 @default.
• W2468222296 cites W2115744148 @default.
• W2468222296 cites W2122845502 @default.
• W2468222296 cites W2125007784 @default.
• W2468222296 cites W2131464730 @default.
• W2468222296 cites W2137927308 @default.
• W2468222296 cites W2140489140 @default.
• W2468222296 cites W2142414417 @default.
• W2468222296 cites W2148857705 @default.
• W2468222296 cites W2149472502 @default.
• W2468222296 cites W2153313089 @default.
• W2468222296 cites W2160382843 @default.
• W2468222296 cites W2163579926 @default.
• W2468222296 cites W2172003877 @default.
• W2468222296 cites W2414553495 @default.
• W2468222296 cites W4243084783 @default.
• W2468222296 cites W2416538303 @default.
• W2468222296 doi "https://doi.org/10.18632/oncotarget.10318" @default.
• W2468222296 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5226571" @default.
• W2468222296 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27367025" @default.
• W2468222296 hasPublicationYear "2016" @default.
• W2468222296 type Work @default.
• W2468222296 sameAs 2468222296 @default.
• W2468222296 citedByCount "24" @default.
• W2468222296 countsByYear W24682222962017 @default.
• W2468222296 countsByYear W24682222962018 @default.
• W2468222296 countsByYear W24682222962019 @default.
• W2468222296 countsByYear W24682222962020 @default.
• W2468222296 countsByYear W24682222962021 @default.
• W2468222296 countsByYear W24682222962022 @default.
• W2468222296 countsByYear W24682222962023 @default.
• W2468222296 crossrefType "journal-article" @default.
• W2468222296 hasAuthorship W2468222296A5003599939 @default.
• W2468222296 hasAuthorship W2468222296A5005324730 @default.
• W2468222296 hasAuthorship W2468222296A5010159755 @default.
• W2468222296 hasAuthorship W2468222296A5014708668 @default.
• W2468222296 hasAuthorship W2468222296A5018758426 @default.

• next